Actively Recruiting

Age: 4Weeks +
All Genders
ID04972604

CureDuchenne Link4: A Resource to Support Research Studies in Duchenne and Becker Muscular Dystrophy (DMD/BMD)

Led by CureDuchenne · Updated on 2024-08-20

5000

Participants Needed

10

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are gathering data and samples from individuals diagnosed with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or carriers of these conditions. This observational study collects clinical information and self- or caregiver-reported data to support research on these neuromuscular disorders. The study aims to provide a valuable resource for researchers by integrating health outcomes with biospecimens for translational research. Participants join through the CureDuchenne Link application, accessible via mobile devices or web, and may participate virtually, at project sites, or community events nationwide. The data collected includes diagnosis information and genetic mutation status upon study entry. Follow-up assessments of functional status, ambulation, walking ability, corticosteroid use, heart and lung health occur every 6 to 12 months for up to ten years. Individuals or their guardians provide consent to share this information, which is stored securely in a HIPAA-compliant data warehouse. Researchers use this data to study DMD and BMD. The study tracks detailed clinical outcomes over time, including the North Star Ambulation Assessment and 6 Minute Walk Test scores. Participants may remain involved for many years, contributing to long-term understanding of these conditions.

CONDITIONS

Brief Title

CureDuchenne Link®: A Resource for Research

Who Can Participate

Age: 4Weeks +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Currently has a confirmed diagnosis of Duchenne or Becker muscular dystrophy based on genetic testing, muscle biopsy, or clinical diagnosis
  • Currently has a confirmed diagnosis of carrier status for Duchenne or Becker muscular dystrophy based on genetic testing
  • Parent or guardian (for minors) or participant provides informed consent and/or assent as required
  • Is 4 weeks of age or older at the time of consent
Not Eligible

You will not qualify if you...

  • Is a foster child or ward of the state
  • Is a prisoner

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (virtual or in-person)

Diagnostic Evaluation

Duration - Up to 1 month

Participants provide information about their diagnosis and genetic mutation status upon study entry or when genetic testing results are available.

1 visit (virtual or in-person)

Long-term Monitoring

Duration - Up to 10 years

Participants are monitored with assessments of functional status, ambulation, corticosteroid use, cardiac and respiratory status every 6 to 12 months for up to 10 years.

Assessments every 6 to 12 months

Trial Site Locations

Total: 10 locations

1

Arkansas Children's Hospital

Little Rock, Arkansas, United States, 72202

Actively Recruiting

2

CureDuchenne

Newport Beach, California, United States, 92660

Actively Recruiting

3

Children's Hospital of Orange County

Orange, California, United States, 92868

Actively Recruiting

4

Rare Disease Research

Atlanta, Georgia, United States, 30329

Actively Recruiting

5

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

6

Kansas University Clinical Research Center

Fairway, Kansas, United States, 66205

Actively Recruiting

7

Corewell Health

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

8

Rare Disease Research Center

Hillsborough, North Carolina, United States, 27278

Actively Recruiting

9

Penn State Health

Hershey, Pennsylvania, United States, 17033

Actively Recruiting

10

Neurology Rare Disease Center

Denton, Texas, United States, 76208

Actively Recruiting

Loading map...

Research Team

E

Erica Rudoff

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 1/2, Open-Label, Dose Escalation Study to Assess the...

Duchenne Muscular Dystrophy

Actively Recruiting

8 locations

A Registered Cohort Study on Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Actively Recruiting

1 location

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Co...

Duchenne Muscular Dystrophy

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here